{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0008661,73,MONDO:0008661,110,-1]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0008661","source":"MONDO:0008661|vitiligo","targets":["NCT01051687|Botulinum Toxin Treatment for Localized Vitiligo|COMPLETED|PHASE4|INTERVENTIONAL","NCT01082393|Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01202513|Topical Bimatoprost Solution 0.03%in Stable Vitiligo|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT01333410|Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01732965|NB-UVB and PUVA Vitiligo Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT03199664|Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04577027|Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of Vitiligo|UNKNOWN|PHASE4|INTERVENTIONAL","NCT04775979|Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo|COMPLETED|PHASE4|INTERVENTIONAL","NCT05008887|Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05536856|Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo|RECRUITING|PHASE4|INTERVENTIONAL","NCT05676333|Secukinumab in Active Non-segmental Vitiligo|COMPLETED|PHASE4|INTERVENTIONAL","NCT06593197|Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients|ENROLLING_BY_INVITATION|PHASE4|INTERVENTIONAL","NCT06991972|Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients|RECRUITING|PHASE4|INTERVENTIONAL","NCT07174024|A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in Stable Non-segmental Vitiligo Patients.|COMPLETED|PHASE4|INTERVENTIONAL","NCT07352293|The Value of Methotrexate in NCES for Stable Vitiligo|RECRUITING|PHASE4|INTERVENTIONAL","NCT07353801|Oral Mini Pulse Dexamethasone in Pediatric Vitiligo|RECRUITING|PHASE4|INTERVENTIONAL","NCT07368673|Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled Trial|COMPLETED|PHASE4|INTERVENTIONAL","NCT00525395|Virus Early Transcription Factor (VETF) Multicenter Phototherapy Protocol|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00631865|Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin|COMPLETED|PHASE3|INTERVENTIONAL","NCT00696358|Excimer Lamp Versus Excimer Laser in Vitiligo Treatment|COMPLETED|PHASE3|INTERVENTIONAL","NCT00807690|Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo|COMPLETED|PHASE3|INTERVENTIONAL","NCT00830713|Vitiligo Skin Transplantation|COMPLETED|PHASE3|INTERVENTIONAL","NCT01087216|Interest of the Dermabrasion by Laser Erbium in the Treatment of the Vitiligo|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01419964|Efficacy and Safety of ACH24 in the Treatment of Vitiligo|WITHDRAWN|PHASE3|INTERVENTIONAL","NCT01629979|Epidermal Cell Transplantation in Vitiligo Skin|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01822379|Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo|WITHDRAWN|PHASE2/PHASE3|INTERVENTIONAL","NCT01841008|Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT02156427|Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism|COMPLETED|PHASE3|INTERVENTIONAL","NCT02191748|Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT02466997|Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC|COMPLETED|PHASE3|INTERVENTIONAL","NCT03611348|Microneedling and Latanoprost in Acrofacial Vitiligo|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT04530344|Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo|COMPLETED|PHASE3|INTERVENTIONAL","NCT04774809|Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT05513924|Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo.|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT06109649|A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT06118411|A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT06163326|A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo|RECRUITING|PHASE3|INTERVENTIONAL","NCT06719024|Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus|RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT00134368|Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT00380471|Treatment and Complication of Bath PUVA in Vitiligo|UNKNOWN|PHASE2|INTERVENTIONAL","NCT01262547|A New Micrografting Technique for Vitiligo|TERMINATED|PHASE2|INTERVENTIONAL","NCT01382589|Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT01511965|Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo|COMPLETED|PHASE1/PHASE2|INTERVENTIONAL","NCT01517893|Clinical Trial of Simvastatin to Treat Generalized Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT01766609|Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo|UNKNOWN|PHASE2|INTERVENTIONAL","NCT01787695|UVA 1 Phototherapy for Vitiligo|UNKNOWN|PHASE2|INTERVENTIONAL","NCT01787708|Efficacy of Red Light in Vitiligo|UNKNOWN|PHASE2|INTERVENTIONAL","NCT01792245|Topical Psoralen Ultraviolet Light A Versus Narrow Band Ultraviolet Light B Treatment for Recalcitrant Dermatoses of the Hand|UNKNOWN|PHASE2|INTERVENTIONAL","NCT01923142|Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo|TERMINATED|PHASE2|INTERVENTIONAL","NCT02432534|Atorvastatin in Active Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT02809976|Topical Ruxolitinib for the Treatment of Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT03036995|Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO|COMPLETED|PHASE2|INTERVENTIONAL","NCT03099304|A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT03123016|Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT03358082|Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo|UNKNOWN|PHASE1/PHASE2|INTERVENTIONAL","NCT03468855|A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT04103060|Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT04237103|Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT04246372|Tofacitinib for Immune Skin Conditions in Down Syndrome|COMPLETED|PHASE2|INTERVENTIONAL","NCT04338581|Evaluation of AMG 714 for Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT04525157|Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)|COMPLETED|PHASE2|INTERVENTIONAL","NCT04811131|Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo|TERMINATED|PHASE2|INTERVENTIONAL","NCT04822584|Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT04896385|A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA)|COMPLETED|PHASE2|INTERVENTIONAL","NCT05210582|A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face|UNKNOWN|PHASE2|INTERVENTIONAL","NCT05247489|A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT05298033|Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo|COMPLETED|PHASE2|INTERVENTIONAL","NCT05342519|Daily Topical Rapamycin for Vitiligo|ACTIVE_NOT_RECRUITING|PHASE2|INTERVENTIONAL","NCT05607316|Evaluating the Efficacy and Safety of Metformin in Vitiligo|WITHDRAWN|PHASE2|INTERVENTIONAL","NCT05872477|Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using Topical Ruxolitinib for Vitiligo in Resistant Areas|COMPLETED|PHASE2|INTERVENTIONAL","NCT05917561|Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo|RECRUITING|PHASE2|INTERVENTIONAL","NCT06790862|A Trial of SHR0302Base in Patients With Vitiligo|ACTIVE_NOT_RECRUITING|PHASE2|INTERVENTIONAL","NCT07152626|Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo|NOT_YET_RECRUITING|PHASE2|INTERVENTIONAL","NCT07181187|Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo|ACTIVE_NOT_RECRUITING|PHASE2|INTERVENTIONAL","NCT00172939|Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model|UNKNOWN|PHASE1|INTERVENTIONAL","NCT01430195|Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)|COMPLETED|PHASE1|INTERVENTIONAL","NCT02281058|Open-label Pilot Study of Abatacept for the Treatment of Vitiligo|UNKNOWN|PHASE1|INTERVENTIONAL","NCT02510651|Effect of Procedural Variables on Outcome of Surgical Treatment of Vitiligo|COMPLETED|PHASE1|INTERVENTIONAL","NCT03973073|Effects of Combination Therapy With Camouflage in the Repigmentation of Vitiligo|COMPLETED|PHASE1|INTERVENTIONAL","NCT04030988|Contribution of Skin Color in Stabilization of Active Cases of Vitiligo by Narrow Band UVB|UNKNOWN|PHASE1|INTERVENTIONAL","NCT04738149|Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment|COMPLETED|EARLY_PHASE1|INTERVENTIONAL","NCT04971200|Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo|COMPLETED|EARLY_PHASE1|INTERVENTIONAL","NCT05293119|Role of Tofacitinib in Vitiligo Patients|UNKNOWN|EARLY_PHASE1|INTERVENTIONAL","NCT05577637|Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo|COMPLETED|PHASE1|INTERVENTIONAL","NCT06602232|A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo|RECRUITING|PHASE1|INTERVENTIONAL","NCT06625177|A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo|ACTIVE_NOT_RECRUITING|PHASE1|INTERVENTIONAL","NCT06813027|Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial.|ACTIVE_NOT_RECRUITING|PHASE1|INTERVENTIONAL","NCT06905873|A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo|RECRUITING|PHASE1|INTERVENTIONAL","NCT07044141|Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo|ACTIVE_NOT_RECRUITING|PHASE1|INTERVENTIONAL","NCT07357870|A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo|RECRUITING|PHASE1|INTERVENTIONAL","NCT07398807|Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo|RECRUITING|EARLY_PHASE1|INTERVENTIONAL","NCT00167752|Psychiatric Problems in Chronic Skin Diseases|COMPLETED|nan|OBSERVATIONAL","NCT00177034|Examination Of Vitiligo Skin Samples Before and After UVB Treatment|TERMINATED|nan|INTERVENTIONAL","NCT00367224|Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo|COMPLETED|nan|INTERVENTIONAL","NCT00368407|Optimal Treatment Frequency of 308-Nm Excimer Laser for Vitiligo on the Face and Neck|COMPLETED|nan|OBSERVATIONAL","NCT00398723|Narrowband UVB Treatment in Patients With Vitiligo|COMPLETED|nan|INTERVENTIONAL","NCT00484224|Audiological Disturbances in Vitiligo|UNKNOWN|nan|OBSERVATIONAL","NCT00509314|The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis|UNKNOWN|nan|OBSERVATIONAL","NCT00615355|Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment|COMPLETED|nan|INTERVENTIONAL","NCT00622180|The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands|COMPLETED|nan|INTERVENTIONAL"]}]}